MicroRNA-138 Promotes Acquired Alkylator Resistance in Glioblastoma by Targeting the BCL-2-Interacting Mediator BIM

Oncotarget - United States
doi 10.18632/oncotarget.7346
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

MicroRNA-221 Promotes Cisplatin Resistance in Osteosarcoma Cells by Targeting PPP2R2A

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Bim: A Novel Member of the BCL-2 Family That Promotes Apoptosis

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
1998English

MicroRNA‑223 Promotes Hepatocellular Carcinoma Cell Resistance to Sorafenib by Targeting FBW7

Oncology Reports
MedicineCancer ResearchOncology
2018English

Reversing Platinum Resistance in Ovarian Cancer Multicellular Spheroids by Targeting BCL-2

OncoTargets and Therapy
OncologyPharmacology
2019English

MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction by Targeting S100A1

PLoS ONE
Multidisciplinary
2013English

MicroRNA‑138‑5p Regulates the Development of Spinal Cord Injury by Targeting SIRT1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2020English

miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting BCL-W and Sox2

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

MicroRNA‑3666 Suppresses the Growth and Migration of Glioblastoma Cells by Targeting KDM2A

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

MicroRNA‑138 Inhibits Tumor Growth and Enhances Chemosensitivity in Human Cervical Cancer by Targeting H2AX

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy